𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Membrane studies in Huntington's disease: Steady-state fluorescence studies of intact erythrocytes

✍ Scribed by Jay W. Pettegrew; John S. Nichols; R. Malcolm Stewart


Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
521 KB
Volume
8
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A futility study of minocycline in Hunti
✍ Dr. Merit Cudkowicz; The Huntington Study Group DOMINO Investigators πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 1 views

## Abstract This study assessed the futility of proceeding with a Phase 3 clinical trial of minocycline as a disease‐modifying treatment for Huntington's disease (HD). One hundred fourteen research participants with HD were randomized, 87 to minocycline (200 mg/d) and 27 to placebo. The change in T

A Genetic Study of red cell osmotic frag
✍ McCormack, Michael K. ;Lazzarini, Alice ;Toke, David ;Lepore, Frederick πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 422 KB πŸ‘ 2 views

## Abstract The erythrocyte osmotic fragility was evaluated on 19 unmedicated subjects with Huntington's disease and 42 individuals at 50% risk, 27 children at 25% risk, and a group of 60 hematologically normal control persons. Five older subjects at 50% risk for Huntington's disease as well as 6 A

Steady-state tryptophan fluorescence spe
✍ Vikas K. Sharma; Devendra S. Kalonia πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 143 KB

The purpose of this work was to obtain information about protein tertiary structure in solid state by using steady state tryptophan (Trp) fluorescence emission spectroscopy on protein powders. Beta-lactoglobulin (betaLg) and interferon alpha-2a (IFN) powder samples were studied by fluorescence spect

Open-label pilot study of levetiracetam
✍ Theresa A. Zesiewicz; Kelly L. Sullivan; Robert A. Hauser; Juan Sanchez-Ramos πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 1 views

## Abstract The objective of this study is to evaluate the tolerability and preliminary efficacy of levetiracetam (LEV) in reducing chorea in Huntington's disease (HD) patients in a prospective open‐label pilot study. Nine HD patients with chorea were treated with LEV in doses up to 3,000 mg/day fo